Cited by

• Fever versus fever: the role of host and vector susceptibility and interspecific competition in shaping the current and future distributions of the sylvatic cycles of dengue virus and yellow fever virus.

  Hanley KA, Monath TP, Weaver SC, Rossi SL, Richman RL, Vasilakis N. Hanley KA, et al. Infect Genet Evol. 2013 Oct;19:292-311. doi: 10.1016/j.meegid.2013.03.008. Epub 2013 Mar 20. Infect Genet Evol. 2013. PMID: 23523817 Free PMC article. Review.
• Complexity of Neutralizing Antibodies against Multiple Dengue Virus Serotypes after Heterotypic Immunization and Secondary Infection Revealed by In-Depth Analysis of Cross-Reactive Antibodies.

  Tsai WY, Durbin A, Tsai JJ, Hsieh SC, Whitehead S, Wang WK. Tsai WY, et al. J Virol. 2015 Jul;89(14):7348-62. doi: 10.1128/JVI.00273-15. J Virol. 2015. PMID: 25972550 Free PMC article. Clinical Trial.
• Sequential dengue virus infections detected in active and passive surveillance programs in Thailand, 1994-2010.

  Bhoomiboonchoo P, Nisalak A, Chansatiporn N, Yoon IK, Kalayanarooj S, Thipayamongkolgul M, Endy T, Rothman AL, Green S, Srikiatkhachorn A, Buddhari D, Mammen MP, Gibbons RV. Bhoomiboonchoo P, et al. BMC Public Health. 2015 Mar 14;15:250. doi: 10.1186/s12889-015-1590-z. BMC Public Health. 2015. PMID: 25886528 Free PMC article.
• Virulence and immunogenicity of a temperature-sensitive dengue-2 virus in lower primates.

  Harrison VR, Eckels KH, Sagartz JW, Russell PK. Harrison VR, et al. Infect Immun. 1977 Oct;18(1):151-6. doi: 10.1128/iai.18.1.151-156.1977. Infect Immun. 1977. PMID: 409682 Free PMC article.
• Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates.

  Guirakhoo F, Weltzin R, Chambers TJ, Zhang ZX, Soike K, Ratterree M, Arroyo J, Georgakopoulos K, Catalan J, Monath TP. Guirakhoo F, et al. J Virol. 2000 Jun;74(12):5477-85. doi: 10.1128/jvi.74.12.5477-5485.2000. J Virol. 2000. PMID: 10823852 Free PMC article.